Pilot Human Studies of FMAU PET in Prostate Cancer
Description: PUBLIC HEALTH RELEVANCE: The goal of our project is to use image-directed biopsy for personalized management of men with suspected prostate cancer. Based on encouraging results of our preclinical and one clinical case evaluation of the cellular proliferation biomarker 18F-2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in conjunction with PET/CT, we now propose to perform a pilot clinical trial in men with suspected prostate cancer. We expect that addition of 18F-FMAU PET/CT directed prostate biopsy to multiparametric MRI and standard TRUS- guided biopsy procedure impacts the clinical management considerably by improving localization and characterization (indolent vs. lethal) of prostate tumors.
Funding type: research
Funder scheme: R21
Start date: 2015-09-04
End date: 2021-06-30
Investigator: HOSSEIN JADVAR (lead)
Institution: University of Southern California
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 30
Funder award ID: R21EB017568
OpenAlex ID: G3812856476
